Development, optimization, standardization, and validation of a simple in-house agar gradient method to determine minimum inhibitory concentration of vancomycin for Staphylococcus aureus

Abstract

BACKGROUND: The Clinical and Laboratory Standards Institute recommends reporting minimum inhibitory concentration (MIC) values of vancomycin for Staphylococcus aureus. Commercial MIC strips are expensive, and the traditional broth microdilution method is cumbersome. With this background, we attempted to develop and standardize an in-house agar gradient method to determine MIC values of vancomycin for S. aureus.

OBJECTIVES: To develop and validate an in-house vancomycin MIC strip, based on simple agar gradient method for S. aureus as per bioassay development guidelines.

MATERIALS AND METHODS: Filter paper gradient strips were made in house and impregnated with varying concentrations of vancomycin to create an antibiotic gradient. During standardization, MICs of ninety clinical strains of S. aureus and ATCC 29213 were tested by the broth microdilution and commercial strip followed by the in-house strip. During the validation stage, MICs of ninety different clinical strains of S. aureus and ATCC 29213 were determined by the in-house strip followed by MIC detection by broth microdilution and commercial strips. A reading of more than ± 1log₂ dilution compared with broth microdilution was considered as an outlier.

RESULTS: During the initial stage, there were 7/90 outliers in the clinical strains, and no outliers were seen with the ATCC 29213 control strain. Corrective action included increasing precaution during the antibiotic impregnation on the strip. During validation stage, only 4/90 outliers were observed in the clinical strains. The commercial strips had 29/90 among clinical and 15/30 outliers in the control strain during the prevalidation phase. Despite maintaining cold chain during the validation phase, the outliers for commercial strip were 18/90 and 4/30 for clinical and control strains, respectively.

CONCLUSION: Reporting vancomycin MIC for S. aureus may be attempted using the in-house method after validating it with a gold standard broth microdilution method and quality control as per protocol.

Key words

AMR - antimicrobial testing - Epsilometer test - in-house agar gradient method - minimum inhibitory concentration - vancomycin

• References

• 1 Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that grow Aerobically; Approved Standard. 10th ed. Wayne, USA: Clinical and Laboratory Standards Institute; 2015. p. M07-A10.
• 2 Jorgensen JH, Howell AW, Maher LA. Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae by using the E-test. J Clin Microbiol 1991;29:109-14.
• 3 Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Twenty Fifth Informational Supplement. Wayne, USA: Clinical and Laboratory Standards Institute; 2015. p. M100-S25.
• 4 Kohner PC, Patel R, Uhl JR, Garin KM, Hopkins MK, Wegener LT, et al. Comparison of agar dilution, broth microdilution, E-test, disk diffusion, and automated vitek methods for testing susceptibilities of Enterococcus spp. to vancomycin. J Clin Microbiol 1997;35:3258-63.
• 5 Available from: http://www.oie.int/fileadmin/Home/eng/Health_standards/aahm/current/chapitre_validation_diagnostics_assays.pdf.
• 6 Collee JG, Marmion BP, Fraser AG, Simmons A, editors. Laboratory control of antimicrobial therapy. Mackie and McCartney Practical Medical Microbiology. Edinburg: Churchill Livingstone; 1996. p. 151-78.
• 7 Marley EF, Mohla C, Campos JM. Evaluation of E-test for determination of antimicrobial MICs for Pseudomonas aeruginosa isolates from cystic fibrosis patients. J Clin Microbiol 1995;33:3191-3.
• 8 Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr., Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American society of health-system pharmacists, the infectious diseases society of America, and the society of infectious diseases pharmacists. Am J Health Syst Pharm 2009;66:82-98.
• 9 Mohd Hafiz AA, Staatz CE, Kirkpatrick CM, Lipman J, Roberts JA. Continuous infusion vs. bolus dosing: Implications for beta-lactam antibiotics. Minerva Anestesiol 2012;78:94-104.
• 10 Olofsson SK, Cars O. Optimizing drug exposure to minimize selection of antibiotic resistance. Clin Infect Dis 2007;45 Suppl 2:S129-36.
• 11 Álvarez R, López Cortés LE, Molina J, Cisneros JM, Pachón J. Optimizing the clinical use of vancomycin. Antimicrob Agents Chemother 2016;60:2601-9.
• 12 Edrington TS, Harvey RB, Farrington LA, Nisbet DJ. Determination of MICs of streptomycin for resistant Salmonella isolates in swine and poultry using a micro-broth dilution system. J Food Prot 2002;65:563-6.
• 13 Balaji V, Jeremiah SS, Baliga PR. Polymyxins: Antimicrobial susceptibility concerns and therapeutic options. Indian J Med Microbiol 2011;29:230-42.